de Jonge E - Search Results

1

The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.

Franco RF, de Jonge E, Dekkers PE, Timmerman JJ, Spek CA, van Deventer SJ, van Deursen P, van Kerkhoff L, van Gemen B, ten Cate H, van der Poll T, Reitsma PH. Franco RF, et al. Among authors: de jonge e. Blood. 2000 Jul 15;96(2):554-9. Blood. 2000. PMID: 10887118 Free article.

2

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van Der Poll T. de Jonge E, et al. Blood. 2000 Feb 15;95(4):1124-9. Blood. 2000. PMID: 10666180 Free article. Clinical Trial.

3

Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.

Juffermans NP, Paxton WA, Dekkers PE, Verbon A, de Jonge E, Speelman P, van Deventer SJ, van der Poll T. Juffermans NP, et al. Among authors: de jonge e. Blood. 2000 Oct 15;96(8):2649-54. Blood. 2000. PMID: 11023494 Free article.

4

Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.

de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van der Poll T. de Jonge E, et al. J Infect Dis. 2001 Jun 15;183(12):1815-8. doi: 10.1086/320723. Epub 2001 May 11. J Infect Dis. 2001. PMID: 11372037 Clinical Trial.

5

Current drug treatment strategies for disseminated intravascular coagulation.

de Jonge E, Levi M, Stoutenbeek CP, van Deventer SJ. de Jonge E, et al. Drugs. 1998 Jun;55(6):767-77. doi: 10.2165/00003495-199855060-00004. Drugs. 1998. PMID: 9617592 Review.

6

Disseminated intravascular coagulation.

Levi M, de Jonge E, van der Poll T, ten Cate H. Levi M, et al. Among authors: de jonge e. Thromb Haemost. 1999 Aug;82(2):695-705. Thromb Haemost. 1999. PMID: 10605770 Review. No abstract available.

7

Sequential measurements of chemokines in urosepsis and experimental endotoxemia.

Olszyna DP, Prins JM, Dekkers PE, De Jonge E, Speelman P, Van Deventer SJ, Van Der Poll T. Olszyna DP, et al. Among authors: de jonge e. J Clin Immunol. 1999 Nov;19(6):399-405. doi: 10.1023/a:1020554817047. J Clin Immunol. 1999. PMID: 10634213

8

Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin.

Lauw FN, ten Hove T, Dekkers PE, de Jonge E, van Deventer SJ, van Der Poll T. Lauw FN, et al. Among authors: de jonge e. Infect Immun. 2000 Mar;68(3):1014-8. doi: 10.1128/IAI.68.3.1014-1018.2000. Infect Immun. 2000. PMID: 10678901 Free PMC article.

9

Endotoxin down-regulates monocyte and granulocyte interleukin-6 receptors without influencing gp130 expression in humans.

Dekkers PE, Juffermans NP, ten Hove T, de Jonge E, van Deventer SJ, van der Poll T. Dekkers PE, et al. Among authors: de jonge e. J Infect Dis. 2000 Mar;181(3):1055-61. doi: 10.1086/315356. J Infect Dis. 2000. PMID: 10720531

10

Granulocyte colony-stimulating factor receptors on granulocytes are down-regulated after endotoxin administration to healthy humans.

Dekkers PE, Juffermans NP, Hove Tt, de Jonge E, van Deventer SJ, van Der Poll T. Dekkers PE, et al. Among authors: de jonge e. J Infect Dis. 2000 Jun;181(6):2067-70. doi: 10.1086/315523. Epub 2000 Jun 5. J Infect Dis. 2000. PMID: 10837195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters